Breaking News Instant updates and real-time market news.

SPX

S&P 500

$0.00 /

+ (+0.00%)

, SPY

SPDR S&P 500 ETF Trust

$270.43 /

+22.36 (+9.01%)

17:23
03/13/20
03/13
17:23
03/13/20
17:23

Trump declares national emergency surrounding COVID-19 outbreak

U.S. President Donald Trump issued a message to Congress declaring a national emergency concerning the COVID-19 outbreak. "Pursuant to section 201 of the National Emergencies Act (50 U.S.C. 1621), I hereby report that I have exercised my authority to declare that the outbreak of coronavirus disease (COVID-19) in the United States constitutes a national emergency," the president said. "This declaration invokes section 1135 of the Social Security Act, 42 U.S.C. 1320b-5, to allow the Secretary of Health and Human Services to exercise the authority under that section to temporarily waive or modify certain requirements of the Medicare, Medicaid, and State Children's Health Insurance programs and of the Health Insurance Portability and Accountability Act Privacy Rule throughout the duration of the public health emergency declared in response to the COVID-19 outbreak."

SPX

S&P 500

$0.00 /

+ (+0.00%)

SPY

SPDR S&P 500 ETF Trust

$270.43 /

+22.36 (+9.01%)

SPX S&P 500
$0.00 /

+ (+0.00%)

03/11/20 Goldman Sachs
Goldman Sachs believes the S&P 500 bull market will soon end
02/27/20 Keefe Bruyette
Stock market may rally Monday on 'Biden bounce,' Keefe Bruyette says
02/24/20
Dow Jones futures decline over 800 points ahead of today's open
12/16/19 Piper Sandler
Piper establishes 2020 S&P 500 price objective of 3,600
SPY SPDR S&P 500 ETF Trust
$270.43 /

+22.36 (+9.01%)

TODAY'S FREE FLY STORIES

Recommendations
TriNet price target raised to $66 from $54 at Credit Suisse » 07:26
10/27/20
10/27
07:26
10/27/20
07:26
TNET

TriNet

$70.57 /

-1.92 (-2.65%)

, ADP

ADP

$145.75 /

-3.36 (-2.25%)

, PAYX

Paychex

$82.40 /

-2.54 (-2.99%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TNET TriNet
$70.57 /

-1.92 (-2.65%)

ADP ADP
$145.75 /

-3.36 (-2.25%)

PAYX Paychex
$82.40 /

-2.54 (-2.99%)

TNET TriNet
$70.57 /

-1.92 (-2.65%)

08/17/20 JPMorgan
TriNet price target raised to $82 from $65 at JPMorgan
07/28/20 Credit Suisse
TriNet price target raised to $54 from $44 at Credit Suisse
07/28/20 Stifel
TriNet price target raised to $79 from $66 at Stifel
04/29/20 Credit Suisse
TriNet price target raised to $44 from $38 at Credit Suisse
ADP ADP
$145.75 /

-3.36 (-2.25%)

09/21/20
Fly Intel: Top five analyst downgrades
09/21/20 Cowen
ADP downgraded to Market Perform on lack of catalysts at Cowen
09/21/20 Cowen
ADP downgraded to Market Perform from Outperform at Cowen
08/17/20 JPMorgan
ADP price target raised to $151 from $138 at JPMorgan
PAYX Paychex
$82.40 /

-2.54 (-2.99%)

10/15/20 Argus
Paychex price target raised to $92 from $83 at Argus
10/12/20 Barclays
Paychex price target raised to $83 from $73 at Barclays
10/08/20
Fly Intel: Top five analyst upgrades
10/08/20 Citi
Paychex upgraded to Buy from Neutral at Citi
TNET TriNet
$70.57 /

-1.92 (-2.65%)

ADP ADP
$145.75 /

-3.36 (-2.25%)

PAYX Paychex
$82.40 /

-2.54 (-2.99%)

TNET TriNet
$70.57 /

-1.92 (-2.65%)

ADP ADP
$145.75 /

-3.36 (-2.25%)

PAYX Paychex
$82.40 /

-2.54 (-2.99%)

Earnings
NeoGenomics reports Q3 EPS 4c, consensus 4c » 07:26
10/27/20
10/27
07:26
10/27/20
07:26
NEO

NeoGenomics

$41.96 /

+0.61 (+1.48%)

Reports Q3 revenue $125M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NEO NeoGenomics
$41.96 /

+0.61 (+1.48%)

NEO NeoGenomics
$41.96 /

+0.61 (+1.48%)

09/09/20 Morgan Stanley
NeoGenomics initiated with an Overweight at Morgan Stanley
08/28/20 Guggenheim
Guggenheim starts oncology testing leader NeoGenomics at Buy
08/28/20 Guggenheim
NeoGenomics initiated with a Buy at Guggenheim
07/29/20 Craig-Hallum
NeoGenomics price target raised to $42 from $36 at Craig-Hallum
NEO NeoGenomics
$41.96 /

+0.61 (+1.48%)

  • 30
    Apr
Hot Stocks
Merck reports Q3 pharmaceutical sales up 2% to $11.3B » 07:26
10/27/20
10/27
07:26
10/27/20
07:26
MRK

Merck

$78.84 /

-1.01 (-1.26%)

The increase was driven…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
Merck initiated with a Buy at Truist
10/16/20 JPMorgan
Merck price target raised to $105 from $98 at JPMorgan
10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

Initiation
Canada Goose initiated with a Buy at Berenberg » 07:25
10/27/20
10/27
07:25
10/27/20
07:25
GOOS

Canada Goose

$33.45 /

-2.045 (-5.76%)

Berenberg analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOS Canada Goose
$33.45 /

-2.045 (-5.76%)

GOOS Canada Goose
$33.45 /

-2.045 (-5.76%)

10/07/20 RBC Capital
Canada Goose price target raised to C$47 from C$43 at RBC Capital
10/07/20 RBC Capital
Canada Goose price target raised to C$47 from C$43 at RBC Capital
10/07/20 Barclays
Canada Goose price target raised to $32 from $30 at Barclays
09/30/20
Fly Intel: Top five analyst upgrades
GOOS Canada Goose
$33.45 /

-2.045 (-5.76%)

GOOS Canada Goose
$33.45 /

-2.045 (-5.76%)

GOOS Canada Goose
$33.45 /

-2.045 (-5.76%)

GOOS Canada Goose
$33.45 /

-2.045 (-5.76%)

Hot Stocks
Ceridian launches Dayforce Benefits Intelligence » 07:25
10/27/20
10/27
07:25
10/27/20
07:25
CDAY

Ceridian

$88.74 /

-3.48 (-3.77%)

Ceridian announced it is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CDAY Ceridian
$88.74 /

-3.48 (-3.77%)

CDAY Ceridian
$88.74 /

-3.48 (-3.77%)

10/23/20 Barclays
Ceridian price target raised to $95 from $76 at Barclays
10/21/20 RBC Capital
Ceridian upgraded to Outperform from Sector Perform at RBC Capital
10/21/20 RBC Capital
Ceridian upgraded to Outperform from Sector Perform at RBC Capital
08/06/20 Wells Fargo
Ceridian price target raised to $93 from $72 at Wells Fargo
CDAY Ceridian
$88.74 /

-3.48 (-3.77%)

  • 26
    Aug
  • 09
    Jun
  • 21
    May
  • 13
    Nov
CDAY Ceridian
$88.74 /

-3.48 (-3.77%)

Recommendations
Thermo Fisher price target raised to $539 from $477 at Needham » 07:25
10/27/20
10/27
07:25
10/27/20
07:25
TMO

Thermo Fisher

$482.52 /

+2.325 (+0.48%)

Needham analyst Stephen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TMO Thermo Fisher
$482.52 /

+2.325 (+0.48%)

TMO Thermo Fisher
$482.52 /

+2.325 (+0.48%)

10/22/20 SVB Leerink
Thermo Fisher price target raised to $525 from $470 at SVB Leerink
10/22/20 BTIG
Thermo Fisher price target raised to $540 from $475 at BTIG
10/22/20 Credit Suisse
Thermo Fisher price target raised to $488 from $432 at Credit Suisse
10/22/20 Baird
Thermo Fisher price target raised to $512 from $481 at Baird
TMO Thermo Fisher
$482.52 /

+2.325 (+0.48%)

TMO Thermo Fisher
$482.52 /

+2.325 (+0.48%)

TMO Thermo Fisher
$482.52 /

+2.325 (+0.48%)

TMO Thermo Fisher
$482.52 /

+2.325 (+0.48%)

Earnings
Ares Capital reports Q3 core EPS 39c, consensus 38c » 07:24
10/27/20
10/27
07:24
10/27/20
07:24
ARCC

Ares Capital

$14.02 /

-0.015 (-0.11%)

Reports Q3 NII per share…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARCC Ares Capital
$14.02 /

-0.015 (-0.11%)

08/05/20 Citi
Ares Capital price target raised to $17 from $15 at Citi
05/07/20 Citi
Ares Capital price target raised to $15 from $13 at Citi
04/16/20 Raymond James
Ares Capital upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Ares Capital upgraded to Outperform from Market Perform at Raymond James
ARCC Ares Capital
$14.02 /

-0.015 (-0.11%)

ARCC Ares Capital
$14.02 /

-0.015 (-0.11%)

Hot Stocks
Merck CEO 'confident' in achieving full-year revenue growth » 07:24
10/27/20
10/27
07:24
10/27/20
07:24
MRK

Merck

$78.84 /

-1.01 (-1.26%)

"We continue to…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
Merck initiated with a Buy at Truist
10/16/20 JPMorgan
Merck price target raised to $105 from $98 at JPMorgan
10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

Hot Stocks
Altair named official supplier for Luna Rossa Prada Pirelli team » 07:24
10/27/20
10/27
07:24
10/27/20
07:24
ALTR

Altair

$45.55 /

-1.87 (-3.94%)

Altair announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALTR Altair
$45.55 /

-1.87 (-3.94%)

ALTR Altair
$45.55 /

-1.87 (-3.94%)

10/14/20 Benchmark
Altair upgraded to Buy from Hold at Benchmark
09/10/20 Guggenheim
Altair upgraded to Neutral from Sell at Guggenheim
08/07/20 JPMorgan
JPMorgan no longer sees Altair underperforming, upgrades to Neutral
08/07/20 JPMorgan
Altair upgraded to Neutral from Underweight at JPMorgan
ALTR Altair
$45.55 /

-1.87 (-3.94%)

Recommendations
Amazon.com price target raised to $3,700 from $3,680 at Credit Suisse » 07:24
10/27/20
10/27
07:24
10/27/20
07:24
AMZN

Amazon.com

$3,209.39 /

+4.42 (+0.14%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMZN Amazon.com
$3,209.39 /

+4.42 (+0.14%)

AMZN Amazon.com
$3,209.39 /

+4.42 (+0.14%)

07:11 Today KeyBanc
Tapestry price target raised to $27 from $20 at KeyBanc
06:40 Today Deutsche Bank
Amazon.com price target raised to $4,050 from $4,000 at Deutsche Bank
10/26/20 Wedbush
Wedbush expects Amazon to report Q3 sales upside, record Q4
10/26/20 JPMorgan
JPMorgan continues to like top pick Amazon into Q3 results
AMZN Amazon.com
$3,209.39 /

+4.42 (+0.14%)

AMZN Amazon.com
$3,209.39 /

+4.42 (+0.14%)

AMZN Amazon.com
$3,209.39 /

+4.42 (+0.14%)

AMZN Amazon.com
$3,209.39 /

+4.42 (+0.14%)

AMZN Amazon.com
$3,209.39 /

+4.42 (+0.14%)

Initiation
Burlington Stores initiated with a Buy at Berenberg » 07:23
10/27/20
10/27
07:23
10/27/20
07:23
BURL

Burlington Stores

$200.33 /

-7.805 (-3.75%)

Berenberg analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BURL Burlington Stores
$200.33 /

-7.805 (-3.75%)

BURL Burlington Stores
$200.33 /

-7.805 (-3.75%)

10/07/20 Barclays
Burlington Stores price target raised to $246 from $238 at Barclays
10/01/20 Loop Capital
Burlington Stores price target raised to $240 from $225 at Loop Capital
08/28/20 Loop Capital
Burlington Stores price target lowered to $225 from $250 at Loop Capital
08/28/20 RBC Capital
Burlington Stores price target raised to $235 from $225 at RBC Capital
BURL Burlington Stores
$200.33 /

-7.805 (-3.75%)

BURL Burlington Stores
$200.33 /

-7.805 (-3.75%)

BURL Burlington Stores
$200.33 /

-7.805 (-3.75%)

Hot Stocks
Apellis, Sobi collobaroate for co-development of systemic pegcetacoplan » 07:23
10/27/20
10/27
07:23
10/27/20
07:23
APLS

Apellis

$35.92 /

+0.11 (+0.31%)

, BIOVF

Swedish Orphan Biovitrum

$0.00 /

+ (+0.00%)

Apellis Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
APLS Apellis
$35.92 /

+0.11 (+0.31%)

BIOVF Swedish Orphan Biovitrum
$0.00 /

+ (+0.00%)

APLS Apellis
$35.92 /

+0.11 (+0.31%)

09/01/20
Fly Intel: Top five analyst initiations
08/31/20 Stifel
Apellis initiated with a Buy at Stifel
07/20/20 Roth Capital
Apellis initiated with a Buy at Roth Capital
06/16/20 BTIG
Apellis initiated with a Neutral at BTIG
BIOVF Swedish Orphan Biovitrum
$0.00 /

+ (+0.00%)

07/22/20 Barclays
Swedish Orphan Biovitrum upgraded to Overweight from Equal Weight at Barclays
06/19/20 Barclays
Barclays upgrades Swedish Orphan to Equal Weight on favorable trends
06/19/20 Barclays
Swedish Orphan upgraded to Equal Weight from Underweight at Barclays
APLS Apellis
$35.92 /

+0.11 (+0.31%)

  • 09
    Jan
Recommendations
Twitter price target raised to $58 from $52 at BofA » 07:23
10/27/20
10/27
07:23
10/27/20
07:23
TWTR

Twitter

$48.99 /

-1.47 (-2.91%)

BofA analyst Justin Post…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWTR Twitter
$48.99 /

-1.47 (-2.91%)

TWTR Twitter
$48.99 /

-1.47 (-2.91%)

06:16 Today JPMorgan
Twitter price target raised to $52 from $39 at JPMorgan
10/26/20 Wedbush
Twitter price target raised to $47 from $37.50 at Wedbush
10/26/20 Mizuho
Twitter price target raised to $45 from $40 at Mizuho
10/22/20 Argus
Snap price target raised to $50 from $30 at Argus
TWTR Twitter
$48.99 /

-1.47 (-2.91%)

TWTR Twitter
$48.99 /

-1.47 (-2.91%)

TWTR Twitter
$48.99 /

-1.47 (-2.91%)

TWTR Twitter
$48.99 /

-1.47 (-2.91%)

Hot Stocks
Casi and BioInvent enter into exclusive license agreement for BI-1206 » 07:23
10/27/20
10/27
07:23
10/27/20
07:23
CASI

Casi Pharmaceuticals

$1.80 /

+0.015 (+0.84%)

BioInvent International …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CASI Casi Pharmaceuticals
$1.80 /

+0.015 (+0.84%)

CASI Casi Pharmaceuticals
$1.80 /

+0.015 (+0.84%)

10/23/20 Oppenheimer
Casi Pharmaceuticals initiated with an Outperform at Oppenheimer
03/24/20 H.C. Wainwright
Casi Pharmaceuticals price target lowered to $3.50 from $7 at H.C. Wainwright
  • 22
    Jul
CASI Casi Pharmaceuticals
$1.80 /

+0.015 (+0.84%)

Hot Stocks
Merck reports Q3 KEYTRUDA sales grew 21% to $3.7B » 07:22
10/27/20
10/27
07:22
10/27/20
07:22
MRK

Merck

$78.84 /

-1.01 (-1.26%)

Q3 Animal Health sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
Merck initiated with a Buy at Truist
10/16/20 JPMorgan
Merck price target raised to $105 from $98 at JPMorgan
10/08/20 Piper Sandler
Moderna regains rights to adult RSV vaccine mRNA-1172, Piper ups target to $136
MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

MRK Merck
$78.84 /

-1.01 (-1.26%)

Hot Stocks
Green Dot, Gig Wage launch long-term partnership » 07:22
10/27/20
10/27
07:22
10/27/20
07:22
GDOT

Green Dot

$57.71 /

-1.92 (-3.22%)

Green Dot and Gig Wage…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GDOT Green Dot
$57.71 /

-1.92 (-3.22%)

GDOT Green Dot
$57.71 /

-1.92 (-3.22%)

10/26/20 BTIG
Green Dot price target raised to $72 from $63 at BTIG
10/26/20 BTIG
Green Dot price target raised to $72 from $63 at BTIG
10/08/20 Needham
Green Dot price target raised to $70 from $62 at Needham
10/05/20 Craig-Hallum
Green Dot price target raised to $70 from $62 at Craig-Hallum
GDOT Green Dot
$57.71 /

-1.92 (-3.22%)

GDOT Green Dot
$57.71 /

-1.92 (-3.22%)

GDOT Green Dot
$57.71 /

-1.92 (-3.22%)

Initiation
Foot Locker initiated with a Buy at Berenberg » 07:21
10/27/20
10/27
07:21
10/27/20
07:21
FL

Foot Locker

$38.07 /

-1.72 (-4.32%)

Berenberg analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FL Foot Locker
$38.07 /

-1.72 (-4.32%)

FL Foot Locker
$38.07 /

-1.72 (-4.32%)

10/13/20
Fly Intel: Top five analyst upgrades
10/13/20 BofA
BofA double upgrades Foot Locker to Buy on Nike product momentum
10/13/20 BofA
Foot Locker upgraded to Buy from Underperform at BofA
10/07/20 Barclays
Barclays upgrades Retail sector to Positive, makes seven rating changes
FL Foot Locker
$38.07 /

-1.72 (-4.32%)

FL Foot Locker
$38.07 /

-1.72 (-4.32%)

FL Foot Locker
$38.07 /

-1.72 (-4.32%)

Hot Stocks
Prevail Therapeutics receives FDA Fast Track designation for PR001 » 07:20
10/27/20
10/27
07:20
10/27/20
07:20
PRVL

Prevail Therapeutics

$10.45 /

-0.39 (-3.60%)

Prevail Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRVL Prevail Therapeutics
$10.45 /

-0.39 (-3.60%)

PRVL Prevail Therapeutics
$10.45 /

-0.39 (-3.60%)

09/14/20 William Blair
Prevail Therapeutics initiated with an Outperform at William Blair
09/11/20
Fly Intel: Top five analyst initiations
09/11/20 Cantor Fitzgerald
Prevail Therapeutics initiated with an Overweight at Cantor Fitzgerald
09/10/20 Cantor Fitzgerald
Prevail Therapeutics initiated with an Overweight at Cantor Fitzgerald
PRVL Prevail Therapeutics
$10.45 /

-0.39 (-3.60%)

PRVL Prevail Therapeutics
$10.45 /

-0.39 (-3.60%)

PRVL Prevail Therapeutics
$10.45 /

-0.39 (-3.60%)

Hot Stocks
Camtek sees Q4 revenue $42M-$44M, consensus $37.77M » 07:19
10/27/20
10/27
07:19
10/27/20
07:19
CAMT

Camtek

$17.98 /

+0.08 (+0.45%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CAMT Camtek
$17.98 /

+0.08 (+0.45%)

CAMT Camtek
$17.98 /

+0.08 (+0.45%)

10/02/20 B. Riley Securities
Camtek price target raised to $21 from $20 at B. Riley Securities
02/19/20 Needham
Camtek initiated with a Buy at Needham
CAMT Camtek
$17.98 /

+0.08 (+0.45%)

Hot Stocks
Bolder Industries to become public through GigCapital2 combination » 07:19
10/27/20
10/27
07:19
10/27/20
07:19
GIX

GigCapital2

$10.19 /

+0.01 (+0.10%)

GigCapital2, a publicly…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Twilio price target raised to $350 from $330 at KeyBanc » 07:19
10/27/20
10/27
07:19
10/27/20
07:19
TWLO

Twilio

/

+

KeyBanc analyst Alex…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWLO Twilio
/

+

TWLO Twilio
/

+

07:04 Today Mizuho
Twilio price target raised to $370 from $350 at Mizuho
06:12 Today Piper Sandler
Twilio price target raised to $365 from $315 at Piper Sandler
05:47 Today Goldman Sachs
Twilio price target raised to $330 from $290 at Goldman Sachs
10/14/20 Benchmark
eGain share price may be benefiting from M&A speculation, says Benchmark
TWLO Twilio
/

+

  • 07
    Aug
TWLO Twilio
/

+

TWLO Twilio
/

+

TWLO Twilio
/

+

Recommendations
Quanta Services price target raised to $74 from $55 at Citi » 07:19
10/27/20
10/27
07:19
10/27/20
07:19
PWR

Quanta Services

/

+

Citi analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PWR Quanta Services
/

+

PWR Quanta Services
/

+

10/21/20 DA Davidson
Quanta Services downgraded to Neutral from Buy at DA Davidson
10/21/20 DA Davidson
Quanta Services downgraded to Neutral from Buy at DA Davidson
09/23/20 Stifel
Quanta Services price target raised to $59 from $50 at Stifel
09/22/20 Bernstein
Quanta Services initiated with an Outperform at Bernstein
PWR Quanta Services
/

+

PWR Quanta Services
/

+

PWR Quanta Services
/

+

PWR Quanta Services
/

+

Hot Stocks
Scholar Rock announces six-month interim analysis from TOPAZ Phase 2 » 07:18
10/27/20
10/27
07:18
10/27/20
07:18
SRRK

Scholar Rock

$13.74 /

-0.47 (-3.31%)

Scholar Rock announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SRRK Scholar Rock
$13.74 /

-0.47 (-3.31%)

SRRK Scholar Rock
$13.74 /

-0.47 (-3.31%)

03/12/20
Fly Intel: Top five analyst initiations
03/11/20 Baird
Scholar Rock initiated with an Outperform at Baird
SRRK Scholar Rock
$13.74 /

-0.47 (-3.31%)

Recommendations
MasTec price target raised to $59 from $50 at Citi » 07:18
10/27/20
10/27
07:18
10/27/20
07:18
MTZ

MasTec

/

+

Citi analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MTZ MasTec
/

+

MTZ MasTec
/

+

08/12/20 UBS
MasTec upgraded to Buy from Neutral at UBS
08/12/20 UBS
MasTec upgraded to Buy from Neutral at UBS
08/03/20 B. Riley FBR
MasTec price target raised to $57 from $46 at B. Riley FBR
08/03/20 Craig-Hallum
MasTec price target raised to $78 from $71 at Craig-Hallum
MTZ MasTec
/

+

  • 20
    Nov
MTZ MasTec
/

+

Recommendations
KBR price target raised to $30 from $28 at Citi » 07:18
10/27/20
10/27
07:18
10/27/20
07:18
KBR

KBR

/

+

Citi analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBR KBR
/

+

KBR KBR
/

+

06/15/20 Citi
KBR price target raised to $29 from $25 at Citi
06/03/20 Goldman Sachs
KBR upgraded to Buy from Neutral at Goldman Sachs
06/03/20 Goldman Sachs
Wabtec downgraded to Neutral from Buy at Goldman Sachs
05/26/20 UBS
KBR upgraded to Buy from Neutral at UBS
KBR KBR
/

+

KBR KBR
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.